Litfulo 50 mg oral capsule

Litfulo (generic name: rituximab) is a monoclonal antibody used primarily for the treatment of certain types of blood cancers and autoimmune diseases. It is commonly used in conditions such as:

1. *Non-Hodgkin Lymphoma (NHL)*: Litfulo is used to treat specific types of NHL in adults.
2. *Chronic Lymphocytic Leukemia (CLL)*: It can be part of the treatment regimen for CLL.
3. *Rheumatoid Arthritis*: Rituximab is used in combination with other medications to treat moderate to severe rheumatoid arthritis in adults who have had an inadequate response to other treatments.
4. *Granulomatosis with Polyangiitis (Wegener's Granulomatosis)* and *Microscopic Polyangiitis*: Rituximab is used to treat these severe autoimmune diseases.

The use of Litfulo must be determined by a healthcare provider, taking into account the specific health condition, treatment goals, and potential side effects. If you are considering this medication, or if you have specific questions about its use, you should consult your healthcare provider for personalized medical advice.